These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25131617)

  • 1. Serum microRNA-124 is a novel biomarker for liver necroinflammation in patients with chronic hepatitis B virus infection.
    Wang JY; Mao RC; Zhang YM; Zhang YJ; Liu HY; Qin YL; Lu MJ; Zhang JM
    J Viral Hepat; 2015 Feb; 22(2):128-36. PubMed ID: 25131617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum microRNA-125b correlates with hepatitis B viral replication and liver necroinflammation.
    Li F; Zhou P; Deng W; Wang J; Mao R; Zhang Y; Li J; Yu J; Yang F; Huang Y; Lu M; Zhang J
    Clin Microbiol Infect; 2016 Apr; 22(4):384.e1-384.e10. PubMed ID: 26802212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between serum S100A9 levels and liver necroinflammation in chronic hepatitis B.
    Wu R; Zhang Y; Xiang Y; Tang Y; Cui F; Cao J; Zhou L; You Y; Duan L
    J Transl Med; 2018 Apr; 16(1):83. PubMed ID: 29615081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. There were no differences in serum HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B with same liver histological necroinflammation grade but differences among grades 1, 2, 3 and 4 apportioned by the same hepatic parenchyma cell volume.
    Ke WM; Xie SB; Li XJ; Zhang SQ; Lai J; Ye YN; Gao ZL; Chen PJ
    J Viral Hepat; 2011 Sep; 18(9):637-45. PubMed ID: 21794025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection.
    Waidmann O; Bihrer V; Pleli T; Farnik H; Berger A; Zeuzem S; Kronenberger B; Piiper A
    J Viral Hepat; 2012 Feb; 19(2):e58-65. PubMed ID: 22239527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of serum Golgi protein 73 for prominent hepatic necroinflammation in chronic HBV infection.
    Xu Z; Shen J; Pan X; Wei M; Liu L; Wei K; Liu L; Yang H; Huang J
    J Med Virol; 2018 Jun; 90(6):1053-1062. PubMed ID: 29424455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.
    Wu IC; Lai CL; Han SH; Han KH; Gordon SC; Chao YC; Tan CK; Sievert W; Tanwandee T; Xu D; Neo BL; Chang TT
    Hepatology; 2010 Apr; 51(4):1185-9. PubMed ID: 20044806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels.
    Park JY; Park YN; Kim DY; Paik YH; Lee KS; Moon BS; Han KH; Chon CY; Ahn SH
    J Viral Hepat; 2008 Aug; 15(8):615-21. PubMed ID: 18573162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of serum HBsAg levels, HBsAg/HBV DNA ratio, and association with liver inflammation activity in HBeAg-positive chronic hepatitis B].
    Li G; Wang J; Bao Y; Zheng L; Ge K; Zhou X; Chen G
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jan; 23(1):40-5. PubMed ID: 25751385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].
    Ying RS; Yang Z; Chen YY; Yang KL; Xiao YH; Wu LJ; Fan HM
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):585-8. PubMed ID: 23207151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
    Karagoz E; Ulcay A; Tanoglu A; Kara M; Turhan V; Erdem H; Oncul O; Gorenek L
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.
    Bihrer V; Friedrich-Rust M; Kronenberger B; Forestier N; Haupenthal J; Shi Y; Peveling-Oberhag J; Radeke HH; Sarrazin C; Herrmann E; Zeuzem S; Waidmann O; Piiper A
    Am J Gastroenterol; 2011 Sep; 106(9):1663-9. PubMed ID: 21606975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B.
    Alam S; Ahmad N; Mustafa G; Shrestha A; Alam AK; Khan M
    Liver Int; 2011 Jul; 31(6):824-30. PubMed ID: 21645213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Chrysanthos N; Georgiou A; Kafiri G; Manolakopoulos S; Tiniakos DG; Giannousis I; Manesis EK; Archimandritis AJ
    Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive serum markers for predicting significant liver histopathology in HBeAg-negative chronic HBV-infected patients with normal alanine aminotransferase.
    Gao Y; Wang M; Liu X
    Microbiol Spectr; 2024 Apr; 12(4):e0394123. PubMed ID: 38426768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a logistic regression model for predicting liver necroinflammation in hepatitis B e antigen-negative chronic hepatitis B patients with normal and minimally increased alanine aminotransferase levels.
    Xie Y; Yi W; Zhang L; Lu Y; Hao HX; Gao YJ; Ran CP; Lu HH; Chen QQ; Shen G; Wu SL; Chang M; Ping-Hu L; Liu RY; Sun L; Wan G; Li MH
    J Viral Hepat; 2019 Jul; 26 Suppl 1():42-49. PubMed ID: 31380591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age as a predictor of significant fibrosis features in HBeAg-negative chronic hepatitis B virus infection with persistently normal alanine aminotransferase.
    Tan Y; Ye Y; Zhou X; Chen L; Wen D
    PLoS One; 2015; 10(4):e0123452. PubMed ID: 25885705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
    Papatheodoridis GV; Manesis EK; Manolakopoulos S; Elefsiniotis IS; Goulis J; Giannousis J; Bilalis A; Kafiri G; Tzourmakliotis D; Archimandritis AJ
    Hepatology; 2008 Nov; 48(5):1451-9. PubMed ID: 18924246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A scoring system for predicting significant fibrosis in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase levels.
    Wang H; Yan R; Zhou Y; Wang MS; Ruo GQ; Cheng MJ
    J Clin Gastroenterol; 2015 Jan; 49(1):69-75. PubMed ID: 24518795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.